ALT
Price:
$5.31
Market Cap:
$468.65M
Altimmune, Inc., a clinical stage biopharmaceutical company, focuses on developing treatments for obesity and liver diseases. The company's lead product candidate, pemvidutide (proposed INN, formerly known as ALT-801), is a GLP-1/glucagon dual receptor agonist that is in Phase 1b trial for the treatment of obesity and non-alcoholic steatohepatitis. It is also developing HepTcell, an immunotherapeutic product candidate, which is in Phase 2 clinical trial for patients chronically infected with the hepatitis B virus. The company was formerly known as Vaxin Inc. and changed its name to Altimmune, Inc. in September 2015. Altimmune, Inc. was founded in 1997 is headquartered in Gaithersburg, Maryla...[Read more]
Industry
Biotechnology
IPO Date
2017-05-26
Stock Exchange
NASDAQ
Ticker
ALT
According to Altimmune, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Altimmune, Inc. over the last ten years is 292.46%. The current 0% Dividend Yield has changed -100.00% with respect to the historical average. Over the past ten years (40 quarters), ALT's Dividend Yield was at its highest in in the March 2017 quarter at 651.99%. The Dividend Yield was at its lowest in in the December 2015 quarter at 0%.
Average
292.46%
Median
0%
Minimum
0%
Maximum
2.92%
Discovering the peaks and valleys of Altimmune, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 2.92%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
| 2019 | 0% | 0% |
| 2018 | 0% | -100.00% |
| 2017 | 2.92% | Infinity% |
| 2016 | 0% | 0% |
| 2015 | 0% | 0% |
The current Dividend Yield of Altimmune, Inc. (ALT) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
292.46%
Altimmune, Inc.’s Dividend Yield is less than DBV Technologies S.A. (0%), less than Annexon, Inc. (0%), less than Korro Bio, Inc. (0%), less than enGene Holdings Inc. (0%), less than Larimar Therapeutics, Inc. (0%), less than Aura Biosciences, Inc. (0%), less than Amarin Corporation plc (0%), less than Alto Neuroscience, Inc. (0%), less than LB Pharmaceuticals Inc Common Stock (0%), less than AC Immune S.A. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $312.18M | |
| 0% | $536.98M | |
| 0% | $63.86M | |
| 0% | $420.82M | |
| 0% | $314.97M | |
| 0% | $409.59M | |
| 0% | $340.44M | |
| 0% | $415.67M | |
| 0% | $487.01M | |
| 0% | $289.73M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Altimmune, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Altimmune, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Altimmune, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Altimmune, Inc. (ALT)?
What is the highest Dividend Yield for Altimmune, Inc. (ALT)?
What is the 3-year average Dividend Yield for Altimmune, Inc. (ALT)?
What is the 5-year average Dividend Yield for Altimmune, Inc. (ALT)?
How does the current Dividend Yield for Altimmune, Inc. (ALT) compare to its historical average?